Related Experiment Video
Updated: Jul 17, 2026

Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis
Vincenzo De Luca1, Daniel J Mueller, Andrea de Bartolomeis
1University of Toronto, Centre for Addiction and Mental Health, Neurogenetics Section, Toronto, ON, Canada. vincenzo_deluca@CAMH.net
Abstract:
The 5-HT2C receptor has been hypothesized to represent an important modulator in feeding behaviour. Evidence was based on the observation that knock-out mice for the 5-HT2C receptor gene (HTR2C) develop obesity and that many atypical antipsychotics with potent 5-HT2C antagonism may induce weight gain in susceptible individuals. Pharmacogenetic studies focusing mainly on the -759C/T promoter polymorphism (rs3813929) of the X-linked HTR2C gene revealed controversial results. We investigated the association of the HTR2C gene and weight gain using meta-analytical techniques, combining all published data while restricting our analysis to studies investigating the 759C/T. We also investigated whether ancestry (Caucasian vs. Asian) and clinical factors moderated any association. We found evidence for a slight association of -759C/T with weight gain and significance between studies for heterogeneity. Our meta-analysis provides support for the association of HTR2C in weight gain but indicates that firmly establishing the role of pharmacogenetics in clinical psychiatry requires much larger sample sizes that have been hitherto reported.
Insights
The serotonin 5-HT2C receptor gene (HTR2C) shows a slight association with weight gain. Larger sample sizes are needed to confirm the role of HTR2C pharmacogenetics in clinical psychiatry.
Area of Science:
- Neuroscience
- Pharmacogenetics
- Genetics
Background:
- The serotonin 5-HT2C receptor (HTR2C) is implicated in regulating feeding behavior.
- HTR2C gene knockout mice exhibit obesity, and some antipsychotics targeting this receptor can cause weight gain.
Purpose of the Study:
- To investigate the association between the HTR2C gene and weight gain.
- To analyze the -759C/T promoter polymorphism (rs3813929) using meta-analytical techniques.
Main Methods:
- Meta-analysis of published studies on the HTR2C -759C/T polymorphism and weight gain.
- Investigation of potential moderation by ancestry (Caucasian vs. Asian) and clinical factors.
Main Results:
- A slight association was found between the HTR2C -759C/T polymorphism and weight gain.
- Significant heterogeneity was observed between studies, suggesting moderating factors.
Conclusions:
- The meta-analysis supports a role for HTR2C in weight gain.
- Larger sample sizes are crucial for definitively establishing the clinical psychiatric relevance of HTR2C pharmacogenetics.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs